1Sanofi Specialty Care, Cambridge, MA;
2Massachusetts College of Pharmacy and Health Sciences University, Manchester, NH;
3Faculty of Medicine, Department of Medical and Surgical Specialties, Transilvania University of Brasov, Romania; and
4Faculty of Medicine, Department of Fundamental Disciplines and Clinical Prevention, Transilvania University of Brasov, Brasov, Romania.
*Address for correspondence: Lorena Dima, MD, PhD, Professor of Pharmacology, Transilvania University of Brasov, Faculty of Medicine, Department of Fundamental Disciplines and Clinical Prevention, 56 Nicolae Bălcescu Str., 500019, Brasov, Romania. E-mail: [email protected]
The authors have no conflicts of interest to declare.
This article is part of a series evaluating drugs recently approved by the U.S. Food and Drug Administration. The series is coordinated by Timothy Nguyen, PharmD and Kristine Willett, PharmD.
Comments (0)